Davies M L, Roberts G T, Stuart N, Wakeman J A
North West Cancer Research Fund Institute, School of Biological Sciences, University of Wales Bangor, Bangor LL57 2UW, UK.
Br J Cancer. 2007 Aug 6;97(3):384-90. doi: 10.1038/sj.bjc.6603873. Epub 2007 Jun 26.
Acquisition of truncating mutations in the adenomatous polyposis coli (APC) protein underlies the progression of the majority of sporadic and familial colorectal cancers. As such, the localisation patterns and interacting partners of APC have been extensively studied in a range of systems, relying on the use of a broad panel of antibodies. Until recently, antibodies to APC have been used largely unchecked. However, several recent reports have been invaluable in clarifying the use of a number of antibodies commonly used to detect APC. Here, we analyse the specificity of a further subset of antibodies to APC. We used a panel of six commercially available antibodies (directed to the amino and carboxy termini of APC) and confirm the detection of full-length APC by immunoblotting. We demonstrate that a 150 kDa protein, also reproducibly detected by this panel of antibodies, is unlikely to be APC. We present data for the immunological staining patterns of the APC antibodies and validate the results through RNAi. Using this approach, we confirm that the apical staining pattern, observed by immunofluorescence and previously reported in cell systems, is unlikely to be APC. Finally, we present our data as a summary of APC-antibody specificities for APC.
腺瘤性息肉病 coli(APC)蛋白截短突变的获得是大多数散发性和家族性结直肠癌进展的基础。因此,APC的定位模式和相互作用伙伴已在一系列系统中得到广泛研究,这依赖于使用多种抗体。直到最近,针对APC的抗体在很大程度上一直未经过严格检验。然而,最近的几份报告对于阐明一些常用于检测APC的抗体的使用情况非常有价值。在这里,我们分析了另一组针对APC的抗体的特异性。我们使用了一组六种市售抗体(针对APC的氨基和羧基末端),并通过免疫印迹法确认了全长APC的检测。我们证明,这组抗体也可重复检测到的一种150 kDa蛋白不太可能是APC。我们展示了APC抗体的免疫染色模式数据,并通过RNA干扰验证了结果。使用这种方法,我们证实了通过免疫荧光观察到的、先前在细胞系统中报道的顶端染色模式不太可能是APC。最后,我们将我们的数据作为APC抗体对APC特异性的总结呈现出来。